IMPACT-RCC
12 april 2021
Watchful waiting in patients with good and intermediate risk metastatic renal cell carcinoma; an imaging guided observational approach. METcnummer: 2014.176 Onderzoekscode: O126 Samenvatting In een deel van de…
Archief
CA209-901
A Phase 3, Open-label, Randomized Study of Nivolumab Combined with Ipilimumab versus Standard of Care Chemotherapy in Participants with Previously Untreated Unresectable or Metastatic Urothelial Cancer (CheckMate 901:…
OncoLifeS Immunotherapie
ICRA
ICRA (Improve Checkpoint-blockade Response in Advanced urothelial cancer), an adaptive clinical study to determine efficacy of combining weekly paclitaxel with tremelimumab +/- durvalumab (MEDI4736) Protocolnummer: ESR-18-13667 EudraCT nummer:…
CA017-078
A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post- Surgery Therapy with Nivolumab or Nivolumab…
Tiger
MOTICA – Longitudinal
Short-term Testosterone Replacement in Testicular Cancer Survivors
Short-term Testosterone replacement in testicular cancer survivors to treat overweight and improve cardiometabolic risk; a pilot study. METc nummer: 2017/436 Onderzoekscode: Samenvatting Het vaststellen van de effecten van…
SEA-CAT
Senescence and the early ageing phenotype after chemotherapy for testicular cancer. The SEA-CAT study Protocolnummer: 201700615 Eudractnummer: METc nummer: 2017/483 Onderzoekscode: Samenvatting Het doel van dit project is…
MOTICA – Cross
Vascular fingerprint
Vascular fingerprint
Vascular fingerprint to identify patients at risk for arterial cardiovascular events within the first year after start of cisplatin-based chemotherapy for testicular cancer: a validation study. METc nummer:…
OncoLifeS Immunotherapie
Safe Stop
Safe Stop Trial: observational study of the STOP & GO strategy of PD-1 blockade in advanced melanoma patients upon achieving a complete or partial response. EudraCT nummer: 2018-001384-23…
OncoLifeS Immunotherapie
CAIRO6
De waarde van peri-operatieve systemische therapie in patiënten die cytoreductieve chirurgie en HIPEC ondergaan voor het peritoneaal gemetastaseerd colorectaal carcinoom: de multicenter, fase II-III, prospectieve, gerandomiseerde CAIRO6 studie….
CAIRO6
De waarde van peri-operatieve systemische therapie in patiënten die cytoreductieve chirurgie en HIPEC ondergaan voor het peritoneaal gemetastaseerd colorectaal carcinoom: de multicenter, fase II-III, prospectieve, gerandomiseerde CAIRO6 studie….
OncoLifeS Immunotherapie
OncoLifeS Immunotherapie
KO-TIP-007
The AIM-HN and SEQ-HN Study: A 2 Cohort, Non-comparative, Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) with HRAS…